Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Finance · ·
$22.96
▲ $0.20 (+0.9%)
Market data updated: 09/29 03:25 PM
Fundamentals updated: 09/29/2026
News analyzed: 09/29/2026
Market Cap
$387.43M
Day Range
$22.86 - $23.19
52-Week Range
$11.37 - $27.24
Beta
—
Next Earnings
09.11.2026
Support
$17.40
Resistance
$27.24
+68.9% (1Y)
Strengths: 12/30 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🟡 Mixed
Technical Trend
🔴 Bearish
Insiders
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Revenue growth (last year)
Revenue growth (last year): 40.8%
Growth
Biggest negative driver
DCF Fair Value
Estimated fair value: -$61.02 vs. price $22.96 (-365.8%)
Fair Value
Signal tension
Growth scores strong (68/100), but fair-value analysis scores this stock as relatively expensive (38/100) — the growth story and the current price aren't fully aligned.
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 3 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 3
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
50
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
68
Quality
47
Value
38
Momentum
46
Risk
54
Sentiment
74
Fundamental
39
Institutional
100
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Prenetics Global Limited has centered on its strong financial momentum and leadership confidence. The company reported record Q2 2026 revenue, with its AI-driven wellness brand IM8 expanding to 140,000 subscribers. Analysts at B. Riley Securities issued a Buy rating with a $37 price target, while CEO Danny Yeung and CFO Brian Rosin made significant open-market share purchases totaling $1 million, signaling leadership optimism. Additionally, IM8 partnered with Lily Collins as a global ambassador, further boosting brand visibility.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Prenetics Global Limited - Class A Ordinary Share. News trend score: 74. Reason: 7 of the last 20 articles are positive, versus 3 negative.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
21
🎯 Conviction (vs. Emotion)
43
Psychology
25
Fundamentals
39
Technical
46
Valuation
38
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
The price rise has far outpaced the actual improvement in fundamental data.
Price (3M)
+28%
Market Narrative
51
Fundamental Reality
43
Narrative Gap
+8
🔀 Psychology Acceleration
News attention/sentiment is running well ahead of the price move itself.
🧠 StockIQ Psychologist
The market behavior for PRE suggests a dominant overconfidence bias, amplified by euphoric momentum (+44.8% ROC) and detached from fundamental growth (+0.3% EPS). The narrative gap (29) hints at a disconnect between market expectations and reality, while FOMO (55) and euphoria (75) indicate aggressive buying. The key question is whether this momentum remains self-sustaining or if fundamentals will eventually reassert. Herding is minimal, suggesting selective participation rather than broad participation.
Updated: 09/09/2026, 12:49 AM
What could change this?
👥 What the crowd believes
"Danny Yeung, CEO, and Brian Rosin, CFO, completed open market purchases of the Company’s shares worth $1.0 million following Q2 results"
"Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million"
"Prenetics’ IM8 Announces Two-Time Golden Globe-Nominated Actress and Producer Lily Collins as IM8 Global Ambassador and Shareholder"
"Prenetics (PRE) stock analysis: IM8 growth to 140k subs, AI-driven marketing"
📈 4D Investor Psychology
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Walter Bagehot — 99/100
🔴 Weakest match
Jack Schwager — 22/100
🗣️ Why do they disagree?
This stock sparks a sharp divide among methodologies, with some seeing it as a resilient or high-growth opportunity while others flag it as speculative or overvalued. The highest scores—from Walter Bagehot (99) and Peter Lynch (84)—suggest it meets strict liquidity or growth criteria, implying a defensive or aggressive buy based on their principles. Meanwhile, Benjamin Graham’s two approaches (83 for Defensive, 50 for Enterprising) reveal a split: one sees it as a solid value play, while the other dismisses it as lacking the deep bargain of his more aggressive bar. On the opposite end, methodologies like Samuel Armstrong Nelson (7) and Charles Mackay (26) warn of overbought conditions or crowd-driven delusions, contrasting sharply with the bullish signals from Lynch or Bagehot. Even moderate scorers like Jesse Livermore (83) and Gerald Loeb (57) lean cautiously optimistic, while the efficient-market camp (37) and Howard Marks (38) question whether the stock’s merits justify active selection over passive strategies or if it’s already priced for peak performance.
Walter Bagehot
Lombard Street (1873)
🟢 99
Strong liquidity — would likely survive a real credit squeeze
Key question
Does this company have enough liquidity to survive real stress?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟢 87
Attractive to a Defensive Graham Investor
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟢 84
Growth candidate — the price hasn't caught up to the growth
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 69
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟡 64
Some signs of crowd excitement building
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟡 63
Reasonable but not a clear long-term holding
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟡 57
Moderate risk to capital
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 57
Some discount, but not the deep 'net-net' bargain Graham's enterprising bar sets
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟡 54
Mixed — a good business, but expectations may already be high
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟡 49
Somewhere in the middle of the cycle
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 41
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 39
Negative trend — against Livermore's core rule of trading with the trend
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 33
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🔴 31
The kind of volatility that tends to shake patient holders out
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🔴 30
Pattern Veblen would flag as growth pursued for its own sake
Key question
Is management building real value, or just building itself?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🔴 22
No real setup here — the discipline Schwager's wizards shared would say stay out
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Based on the last 289 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (3 bullish · 6 bearish · 2 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a clear uptrend with no defined trading range in the period examined.
Medium confidence
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
53.5%
Operating Margin
-48.1%
Net Margin
-40.8%
EBITDA Margin
—
ROE
-24.1%
ROA
-18.3%
ROIC
—
EPS
-$3.71
Cash
$52.25M
Total Debt
—
Current Ratio
2.97
Debt/Equity
0.01
How is Fair Value calculated? →
Current Price
$22.96
Estimated Fair Value (DCF)
-$61.02
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-365.8%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
25.0%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 25.0% | $-37.35M | $-34.27M |
| 2 | 19.4% | $-44.59M | $-37.53M |
| 3 | 13.8% | $-50.72M | $-39.16M |
| 4 | 8.1% | $-54.84M | $-38.85M |
| 5 | 2.5% | $-56.21M | $-36.53M |
Base FCF (last actual year)
$-29.88M
Terminal Value
$-886.37M
Present Value of Terminal Value
$-576.08M
Enterprise Value
$-762.42M
Net Debt
$0
Equity Value
$-762.42M
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$13.89
Tangible Book Value per Share (Tangible NAV)
$13.89
Sentiment based on basic keywords (not AI) — 7 positive, 10 neutral, 3 negative out of the last 20 articles.
MT Newswires · 17.9.2026
GlobeNewswire · 15.9.2026
Benzinga · 27.8.2026
Yahoo · 26.8.2026
GlobeNewswire · 26.8.2026
MT Newswires · 26.8.2026
Benzinga · 26.8.2026
SeekingAlpha · 24.8.2026
SeekingAlpha · 22.8.2026
GuruFocus.com · 21.8.2026
GlobeNewswire · 20.8.2026
Moby · 19.8.2026
MarketBeat · 18.8.2026
Stocktwits · 18.8.2026
GlobeNewswire · 18.8.2026
Zacks Small Cap Research · 18.8.2026
Benzinga · 18.8.2026
Benzinga · 18.8.2026
Benzinga · 18.8.2026
Benzinga · 18.8.2026
Prenetics Global Limited - Class A Ordinary Share (PRE) currently has a StockIQ AI score of 50/100, rated "Moderate". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
PRE currently scores 50/100 (Moderate) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, PRE's estimated fair value is -$61.02, which is 365.8% below the current price of $22.96. This is one valuation model among several signals in the fair-value category, not a price target.
PRE's technical score is 46/100, which currently reads as neutral — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Revenue growth (last year): 40.8%; Earnings per share (EPS) growth: 33.5%; Net income growth: 23.1%.
Based on the real signals StockIQ computed: Estimated fair value: -$61.02 vs. price $22.96 (-365.8%); Operating margin: -48.1% (negative); Net margin: -40.8% (negative).
StockIQ has no recorded dividend payment history for PRE.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 10 purchases and 0 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Leogrande Hudson Blake | Exercise of Derivative Securities | 4.9.2026 | 2,000 | +2,000 | — |
| Leogrande Hudson Blake | Exercise of Derivative Securities | 4.9.2026 | 2,000 | -2,000 | — |
| Tat Thuan Yen | Grant/Award from Employer | 3.9.2026 | 10,730 | +10,730 | — |
| Rosin Brian J | Open Market Purchase | 25.8.2026 | 23,100 | +5,100 | $22.80 |
| Rosin Brian J | Open Market Purchase | 25.8.2026 | 5,100 | +5,100 | $22.80 |
| Yeung Danny Sheng Wu | Open Market Purchase | 24.8.2026 | 101,235 | +6,000 | $20.90 |
| Rosin Brian J | Open Market Purchase | 24.8.2026 | 18,000 | +18,000 | $21.19 |
| Yeung Danny Sheng Wu | Open Market Purchase | 24.8.2026 | 112,416 | +11,181 | $21.40 |
| Rosin Brian J | Open Market Purchase | 24.8.2026 | 18,000 | +18,000 | $21.19 |
| Yeung Danny Sheng Wu | Open Market Purchase | 24.8.2026 | 6,000 | +6,000 | $20.90 |
| Yeung Danny Sheng Wu | Open Market Purchase | 24.8.2026 | 11,181 | +11,181 | $21.40 |
| Lo Hoi Chun | Exercise of Derivative Securities | 21.8.2026 | 61,086 | -45,815 | — |
| Lo Hoi Chun | Exercise of Derivative Securities | 21.8.2026 | 566,013 | +32,736 | $0.00 |
| Lo Hoi Chun | Exercise of Derivative Securities | 21.8.2026 | 45,815 | +45,815 | — |
| Lo Hoi Chun | Exercise of Derivative Securities | 21.8.2026 | 491,029 | -491,029 | $0.00 |
| Lo Hoi Chun | Exercise of Derivative Securities | 21.8.2026 | 32,736 | +32,736 | $0.00 |
| Lo Hoi Chun | Exercise of Derivative Securities | 21.8.2026 | 45,815 | -45,815 | — |
| Yeung Danny Sheng Wu | Other Transaction | 20.8.2026 | 87,735 | -49,912 | — |
| Yeung Danny Sheng Wu | Exercise of Derivative Securities | 20.8.2026 | 137,647 | +53,953 | $0.00 |
| Yeung Danny Sheng Wu | Open Market Purchase | 20.8.2026 | 95,235 | +7,500 | $18.31 |
| Yeung Danny Sheng Wu | Exercise of Derivative Securities | 20.8.2026 | 0 | -809,295 | $0.00 |
| Yeung Danny Sheng Wu | Exercise of Derivative Securities | 20.8.2026 | 809,295 | -809,295 | $0.00 |
| Yeung Danny Sheng Wu | Other Transaction | 20.8.2026 | 49,912 | -49,912 | — |
| Yeung Danny Sheng Wu | Open Market Purchase | 20.8.2026 | 7,500 | +7,500 | $18.31 |
| Yeung Danny Sheng Wu | Exercise of Derivative Securities | 20.8.2026 | 53,953 | +53,953 | $0.00 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
517,569 shares short as of 2026-09-15 · vs. 598,224 on 2026-08-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
45.9% of trading volume this week was short selling, vs. 50.9% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology